Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: solid (48), dense (12), thick (51)

Capecitabine-Cisplatin-Epirubicin (ECX)

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE, CISPLATIN and EPIRUBICIN (ECX) Regimen • Gastrointestinal Cancer (upper) – Capecitabine-Cisplatin-Epirubicin (ECX) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Epirubicin.pdf

Capecitabine-Lapatinib

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE-LAPATINIB This protocol may require funding Regimen • Breast Can
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CapecitabineLapatinib.pdf

Prostate artery embolisation - patient information

Description: This factsheet explains what is involved in having a prostate artery embolisation (PAE) and outlines the possible risks.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Prostate-artery-embolisation-2244-PIL.pdf

Hepatitis C: information for people who have used drugs - patient information

Description: Hepatitis C is a curable illness which is mainly spread via blood-to-blood contact.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Hepatitis-C-information-for-people-who-have-used-drugs-542-PIL.pdf

Capecitabine-Oxaliplatin 4-cycles

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and OXALIPLATIN (CAPOX-4 cycles) Regimen • Colorectal Cancer – Capecitabine-Oxaliplatin 4 cycles (CAPOX-4 cycles) Indication • Ad
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Oxaliplatin-4-cycles.pdf

Superficial thrombophlebitis - patient information

Description: Patient information factsheet Superficial thrombophlebitis We have written this factsheet to give you information on superficial thrombop
Url: /Media/UHS-website-2019/Patientinformation/Blooddisorders/Superficial-thrombophlebitis-2267-PIL.pdf

Your personal data and your rights - patient information

Description: As part of your care at University Hospital Southampton we will need to collect information about you. This data is vital
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Your-personal-data-and-your-rights.pdf

VR-RituximabVenetoclax Cycle_2 Onwards

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) (Cycle 2 onwards) Regimen • CLL – VR Rituxi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclax-Cycle-2-Onwards.pdf

VenetoclaxLow

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (low risk) Funding may be required for this regimen. Regimen • CLL –
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxLow.pdf

IdelalisibRituximab

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Idelalisib-Rituximab Regimen • CLL – Idelalisib-Rituximab Indication • Chronic lymphocytic l
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/IdelalisibRituximab.pdf

431 to 440 of 533

Previous … 42 43 44 45 46 … Next